Immediate Impact
57 standout
Citing Papers
Emerging Delivery Systems for Enabling Precision Nucleic Acid Therapeutics
2025 Standout
Pluripotent stem-cell-derived therapies in clinical trial: A 2025 update
2025 Standout
Works of Junshan Qiu being referenced
FDA Approval Summary: Fam-Trastuzumab Deruxtecan-Nxki for the Treatment of Unresectable or Metastatic HER2-Positive Breast Cancer
2021
FDA Approval Summary: Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Junshan Qiu | 124 | 53 | 14 | 118 | 72 | 19 | 390 | |
| Cynthia Basu | 46 | 27 | 220 | 188 | 21 | 355 | ||
| Pierre Squifflet | 40 | 26 | 210 | 85 | 20 | 399 | ||
| Gwynn Ison | 68 | 86 | 1 | 208 | 13 | 16 | 416 | |
| Jamal A. Al-Saleh | 40 | 22 | 2 | 38 | 57 | 22 | 416 | |
| Kyung Mann Kim | 95 | 29 | 102 | 17 | 16 | 358 | ||
| C.E. Newman | 24 | 12 | 2 | 152 | 37 | 18 | 366 | |
| Ratislav Bahleda | 39 | 29 | 1 | 213 | 22 | 31 | 449 | |
| Enrico Tendi | 26 | 64 | 4 | 83 | 153 | 23 | 345 | |
| Stephen D. Mills | 82 | 10 | 1 | 48 | 64 | 15 | 364 | |
| Marie-Anne Damiette Smit | 13 | 45 | 249 | 63 | 11 | 385 |
All Works
Login with ORCID to disown or claim papers
Loading papers...